Current Clinical Trials
Listed below you will find clinical trials that are taking place at LIMR. Additionally, Main Line Health has various clinical trials through the Community Clinical Oncology Program (CCOP) and the Heart Center. For further general infomation about clinical trials please contact LIMR's Clinical Research Center at 484-476-3343.
|
|
 |
| RELY-ABLE -Extension to the RE-LY Study |
DESCRIPTION:
RE-LY participants were individuals with atrial fibrillation who require long term anti-coagulation. The only eligible patients for RELY-ABLE are those who participated in RE-LYand were assigned to receive dabigatran.
STATUS:
Closed to accrual. This study is no longer accepting new patients.
LIMR/MLH INVESTIGATOR:
Michael D. Ezekowitz, MD, PhD
SPONSOR:
Boehringer-Ingelheim Pharmaceuticals
CONTACT:
RELY-ABLE Study Team - 484.476.3343 or CRC@mlhs.org
|
 |
|
 |
| A Phase 0, Open Label, Non-Randomized, Multicenter, Exploratory, and Safety Study of [F-18]W372 |
DESCRIPTION:
Patients with early Alzheimer's Disease may be eligible to participate in this study of a new drug for use in future studies of brain imaging in early Alzheimer's Disease.
STATUS:
Closed to accrual. This study is no longer accepting new patients.
LIMR/MLH INVESTIGATOR:
Majorie Marenberg, MD, PhD
SPONSOR:
Siemens Molecular Imaging
CONTACT:
Judy Spahr - 484-476-4625
|
 |
|